Literature DB >> 17408415

Hyperbilirubinemia interferes with ADAMTS-13 activity measurement by FRETS-VWF73 assay: diagnostic relevance in patients suffering from acute thrombotic microangiopathies.

S C Meyer, I Sulzer, B Lämmle, J A Kremer Hovinga.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17408415     DOI： 10.1111/j.1538-7836.2007.02438.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  18 in total

Review 1.  Clinical and laboratory diagnosis of TTP: an integrated approach.

Authors:  Thita Chiasakul; Adam Cuker
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

Review 2.  Thrombotic thrombocytopenic purpura: pathogenesis, diagnosis and potential novel therapeutics.

Authors:  M Saha; J K McDaniel; X L Zheng
Journal:  J Thromb Haemost       Date:  2017-07-27       Impact factor: 5.824

Review 3.  ADAMTS13 and von Willebrand factor in thrombotic thrombocytopenic purpura.

Authors:  X Long Zheng
Journal:  Annu Rev Med       Date:  2015       Impact factor: 13.739

4.  Idiopathic noncirrhotic intrahepatic portal hypertension is associated with sustained ADAMTS13 Deficiency.

Authors:  Ian Mackie; C E Eapen; Desley Neil; Andrew S Lawrie; Andrew Chitolie; Jean C Shaw; Elwyn Elias
Journal:  Dig Dis Sci       Date:  2011-05-15       Impact factor: 3.199

5.  Unconjugated bilirubin inhibits proteolytic cleavage of von Willebrand factor by ADAMTS13 protease.

Authors:  R-N Lu; S Yang; H M Wu; X L Zheng
Journal:  J Thromb Haemost       Date:  2015-04-23       Impact factor: 5.824

6.  Thrombotic thrombocytopenic purpura: diagnostic criteria, clinical features, and long-term outcomes from 1995 through 2015.

Authors:  Evaren E Page; Johanna A Kremer Hovinga; Deirdra R Terrell; Sara K Vesely; James N George
Journal:  Blood Adv       Date:  2017-04-06

7.  A shear-based assay for assessing plasma ADAMTS13 activity and inhibitors in patients with thrombotic thrombocytopenic purpura.

Authors:  Yue Han; Juan Xiao; Erica Falls; X Long Zheng
Journal:  Transfusion       Date:  2011-01-20       Impact factor: 3.157

Review 8.  Pivotal role of ADAMTS13 function in liver diseases.

Authors:  Masahito Uemura; Yoshihiro Fujimura; Saiho Ko; Masanori Matsumoto; Yoshiyuki Nakajima; Hiroshi Fukui
Journal:  Int J Hematol       Date:  2010-01       Impact factor: 2.490

Review 9.  The kidney in thrombotic thrombocytopenic purpura.

Authors:  H-M Tsai
Journal:  Minerva Med       Date:  2007-12       Impact factor: 4.806

10.  An optimized fluorogenic ADAMTS13 assay with increased sensitivity for the investigation of patients with thrombotic thrombocytopenic purpura.

Authors:  J Muia; W Gao; S L Haberichter; L Dolatshahi; J Zhu; L A Westfield; S C Covill; K D Friedman; J E Sadler
Journal:  J Thromb Haemost       Date:  2013-08       Impact factor: 5.824
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.